Keywords: BGI-Shenzhen, Complete Genomics, Mitsui, Arch Pharmalabs, M&A, Genome sequencing, APIs

China's BGI-Shenzhen to acquire Complete Genomics; Mitsui ups stake in Arch Pharmalabs

Article | 18 September 2012

Print This

Complete Genomics (Nasdaq: GNOM) yesterday revealed that it has entered into a definitive merger agreement to be acquired by China& ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in